Loading...
XSTO
SDOS
Market cap4mUSD
Jul 10, Last price  
0.85SEK
1D
6.25%
1Q
-13.27%
Jan 2017
-81.80%
IPO
-93.77%
Name

ScandiDos AB

Chart & Performance

D1W1MN
XSTO:SDOS chart
P/E
—
P/S
0.89
EPS
—
Div Yield, %
—
Shrs. gr., 5y
6.58%
Rev. gr., 5y
-2.00%
Revenues
54m
-10.27%
28,933,00035,979,00039,834,00038,699,00032,923,00033,576,00047,408,00050,570,00048,824,00057,271,00059,990,00057,684,00061,550,00060,429,00060,429,00054,222,000
Net income
-3m
L-76.55%
321,000227,000-2,093,000-4,200,000-14,683,000-14,242,000-13,157,000-11,565,000-17,761,000-13,134,000-1,399,000-7,338,000-9,119,000-14,647,000-14,647,000-3,435,000
CFO
-3m
L
2,311,000-4,437,000-10,779,000-18,559,000-13,168,000-9,167,000-13,315,000-5,664,0008,638,0002,391,000-11,902,0001,485,000230,000-2,925,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, such as VMAT, RapidArc, IMRT, and Tomotherapy. It sells its products directly to consumers and through distributors. ScandiDos AB (publ) was founded in 2001 and is headquartered in Uppsala, Sweden.
URL
https://scandidos.com/
IPO date
Apr 11, 2014
Employees
31
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑042025‑042024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT